Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | LTA4H | P09960 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1451503 | 0.90 | CA1 (0.65) | CA4LTA4HCA1CA2CA7 | |
| SCHEMBL9930633 | 0.86 | CA4 (0.48) | CA4LTA4HCA1CA2CA7 | |
| Tetraphenylphosphonium SCHEMBL17271410 | 0.86 | CA4 (0.48) | CA4LTA4HCA1CA2CA7 | |
| SCHEMBL3139194 | 0.84 | CA4 (0.46) | CA4LTA4HCA1CA2CA7 | |
| SCHEMBL3143783 | 0.84 | CA4 (0.46) | CA4LTA4HCA1CA2CA7 | |
| Tetramethylammonium Ion SCHEMBL3618056 | 0.83 | CA1 (0.55) | CA4LTA4HCA1CA2CA7 | |
| SCHEMBL20841983 | 0.78 | NFE2L2 (0.56) | ALDH1A1LMNAKDM4EL3MBTL1CYP1A2 | |
| SCHEMBL291776 | 0.77 | CA4 (0.68) | CA4LTA4HCA1CA2CA7 | |
| SCHEMBL9152375 | 0.77 | CA4 (0.68) | CA4LTA4HCA1CA2CA7 | |
| SCHEMBL17283658 | 0.77 | CA4 (0.68) | CA4LTA4HCA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2980180-A1 | PHOTOBASE GENERATOR | San-Apro Ltd. (JP) | 2016-02-03 | — | — | EP | disclosed |
| US-20160009737-A1 | PHOTOBASE GENERATOR | SAN-APRO LTD. (JP) | 2016-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160009737-A1 | PHOTOBASE GENERATOR | PSMC6, ARCN1, CRY1 | CA4 1471/4885LTA4H 2432/4885CA1 666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.